Group Management Governance Work Experience Dr Prem Kumar Nair was appointed Group Chief Executive Officer of IHH Healthcare on 1 October 2023, where he leads a team of more than 70,000 employees to realise IHH’s vision to be the world’s most trusted healthcare services network. Dr Nair sets the strategic direction for the sustainable growth of IHH’s global network which today comprises more than 80 hospitals in 10 countries. Guided by its Care. For Good. aspiration, Dr Nair continues to build on the IHH portfolio of strong and reputable brands including Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway – to touch lives and transform care globally. Prior to his Group CEO appointment, he was CEO of IHH Singapore, where he oversaw the operations and management of IHH’s business units in the country and played an instrumental role in its strategic business growth and outreach efforts in overseas markets. Dr Nair is a physician and healthcare executive with over three decades of experience in both public and private healthcare sectors. He was with Raffles Medical Group for 27 years, where he held concurrent roles as Chief Corporate Officer, and Managing Director for Singapore Healthcare. He is an Adjunct Associate Professor at the National University of Singapore’s Saw Swee Hock School of Public Health. An active community citizen, Dr Nair was a recipient of the Public Service Medal (Pingat Bakti Masyarakat) and the Public Service Star (Bintang Bakti Masyarakat) at the 2010 and 2022 National Day Awards respectively, for his contributions to the Singapore Prison Service. He is also a Justice of the Peace. Academic/Professional Qualification(s) • Bachelor of Medicine & Surgery, National University of Singapore • Master of Business Administration (Distinction), Manchester Business School, United Kingdom Dr Prem Kumar Nair Group Chief Executive Officer Nationality: Singaporean Gender: Male Age: 63 (As at 5 April 2024) Date of Appointment: 1 October 2023 Notes • Does not have any family relationships with any directors and/or any major shareholders of the Company • Does not have any conflict of interest with the Company • Does not have any convictions for offences within the past five years other than for traffic offences, if any Work Experience Mr Dilip Kadambi, who transitioned from his prior role as Group Head of Corporate Finance and Treasury, assumed the position of Group Chief Financial Officer as of 5 April 2024. In his new capacity, Mr Kadambi is responsible for overseeing the financial strategy and management of the IHH Healthcare network. Mr Kadambi first joined IHH in May 2020 as Group Head of Business Transformation and subsequently evolved his role to corporate finance and treasury, even double-hatting as interim Head of Group Procurement. He has over 27 years of leadership experience in multinational companies, specialising in investment banking, merger and acquisitions, and capital markets. Prior to IHH, he was the Interim Group Chief Executive Officer & Group Chief Financial Officer of Columbia Asia Healthcare, Singapore & Malaysia between 2015 and April 2020. He had also worked in numerous banking institutions including Standard Chartered Bank (Singapore), CIMB Bank Berhad (Singapore), Royal Bank of Scotland (Singapore and India) and ABN AMRO Bank (India). Academic/Professional Qualification(s) • Post Graduate Diploma in Business Administration, Institute of Chartered Financial Analyst • Bachelor of Commerce, Madras University, India Dilip Kadambi Group Chief Financial Officer Nationality: Indian Gender: Male Age: 49 (As at 5 April 2024) Date of Appointment: 5 April 2024 IHH Healthcare Berhad 78
RkJQdWJsaXNoZXIy NDgzMzc=